Selective coronary venous bypass grafting for diffuse right coronary artery disease: early safety, uncertain durability Authors: Sebastian Veliz Padilla Published: 2026 We read with great interest the article by Dai et al. entitled “Selective coronary vein bypass graft improves outcomes in patients with right coronary artery lesions”, in which the authors address one of the most complex scenarios in contemporary coronary surgery: revascularization of the right coronary artery with diffuse disease (1). In this study, the authors evaluated selective coronary vein bypass as an alternative strategy in patients for whom conventional surgical approaches, including coronary endarterectomy, may be technically demanding or associated with a higher perioperative risk. In this study, the authors reported that selective coronary vein bypass was associated with a lower incidence of perioperative myocardial infarction and major adverse cardiovascular events (MACEs) compared with coronary endarterectomy, even after adjustment using propensity score matching (1). These results are clinically relevant, considering the perioperative period, which represents a critical stage in patients with diffuse coronary artery disease. However, despite the reported decrease in perioperative events, the study showed no significant differences in survival or in the incidence of MACE during long-term follow-up (1). This finding raises the question of whether the early benefit associated with venous reperfusion is sufficient to modify the long-term clinical prognosis. The accumulated experience in complex coronary surgery demonstrates that perioperative results, even when clinically relevant, do not always reflect the impact of a technique on long-term prognosis. In this regard, Kelly et al. analyzed a large multicenter database and reported that coronary endarterectomy combined with bypass is associated with a higher risk of early complications, but no significant differences in long-term survival were found between patients who underwent endarterectomy and those treated with coronary bypass without endarterectomy (2). On the other hand, Bagheri et al., in a long-term follow-up study, demonstrated that, despite a higher initial morbidity, the late mortality of patients undergoing coronary endarterectomy was not significantly different from that observed in the group treated with isolated bypass; however, the endarterectomy group had a slightly higher incidence of MACE in the established follow-up period (3). These findings highlight that the evaluation of the clinical benefit of different complex surgical techniques necessarily requires considering the medium and long-term results, beyond the perioperative period. In conclusion, the study by Dai et al. provides relevant evidence on the potential of selective coronary venous bypass as a strategy to reduce perioperative complications in patients with diffuse right coronary artery disease (1). However, the absence of a clear long-term clinical benefit highlights the importance of having objective long-term assessments. In this context, studies focused on graft and revascularized vessel patency, such as that by Ellouze et al., have demonstrated that computed tomography angiography is a key tool for interpreting the durability of complex surgical techniques (4). In turn, experimental models of selective venous reperfusion, described by Harig et al., have shown preservation of myocardial function and tissue viability during prolonged follow-up, although this evidence comes primarily from preclinical studies and still requires robust clinical validation in humans (5). Consequently, we believe that the true clinical role of selective venous bypass can be defined through prospective, multicenter studies that incorporate long-term follow-up, imaging evaluation, and realistic clinical outcomes. Supplementary The article’s supplementary files as